Compare LI & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LI | VTR |
|---|---|---|
| Founded | 2015 | 1983 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Real Estate Investment Trusts |
| Sector | Consumer Discretionary | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 45.0B |
| IPO Year | 2019 | 2005 |
| Metric | LI | VTR |
|---|---|---|
| Price | $12.50 | $88.85 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 13 |
| Target Price | $19.66 | ★ $87.62 |
| AVG Volume (30 Days) | ★ 3.5M | 3.0M |
| Earning Date | 05-28-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.38% |
| EPS Growth | N/A | ★ 184.21 |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $5,833,980,000.00 |
| Revenue This Year | $18.98 | $14.00 |
| Revenue Next Year | $22.72 | $8.35 |
| P/E Ratio | ★ $29.50 | $334.58 |
| Revenue Growth | N/A | ★ 18.47 |
| 52 Week Low | $11.65 | $66.38 |
| 52 Week High | $26.94 | $101.60 |
| Indicator | LI | VTR |
|---|---|---|
| Relative Strength Index (RSI) | 46.28 | 38.49 |
| Support Level | $11.86 | $84.56 |
| Resistance Level | $13.16 | $91.06 |
| Average True Range (ATR) | 0.29 | 2.72 |
| MACD | 0.01 | -1.18 |
| Stochastic Oscillator | 29.80 | 4.33 |
Li Auto is one of China's leading new energy vehicle manufacturers. Founded in 2015, the company designs, develops, manufactures, and sells premium smart NEVs with a particular focus on family size premium SUVs and MPVs. Li Auto started volume production of its first model—the Li One, an SUV that is a premium plug-in electric vehicle- in November 2019. Besides PHEVs, its product portfolio now extends to EVs that are fully battery-powered, reaching a wide audience. It has sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger NEV market.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.